Autism spectrum disorder: the NICE guidelines

Author/s
Gillian Baird
Citation
Issue 4 Summer 2014
CEPiP.2014.1.87-97
Abstract

The National Institute for Health and Care Excellence (NICE) Guidelines on Autism consist of three publications Autism: recognition, referral and diagnosis of children and young people on the autism spectrum (NICE clinical guideline 128), Autism: recognition, referral, diagnosis and management of adults on the autism spectrum (NICE clinical guideline 142) and Autism: the management and support of children and young people on the autism spectrum (clinical guideline 170 published in 2013). As a suite of guidelines with associated information, including audit tools and pathways, the intention is to promote guidance for a seamless service across the life span. Autism is the term used in the guidelines to encompass all diagnoses of ‘pervasive developmental disorder/autism spectrum disorder’ and subgroups as in recent Department of Health, National Audit Office and Public Accounts Committee documents. The guidelines draw together systematic reviews and expert opinion to produce clinical practice recommendations covering recognition, referral, diagnosis, interventions, both psychosocial and pharmacological, as well as organisation of services for children, young people and adults. This article summarises the key practice recommendations, highlights where gaps remain in the evidence base and describes some of the challenges for implementing the guidelines in routine clinical practice.

Cite as: Cutting Edge Psychiatry in Practice 2014, 4(1):87-97; https://doi.org/10.65031/fpwl8436

References

  1. World Health Organization. International statistical classification of diseases and related health problem (ICD-10). www.who.int/classifications/icd/en/bluebook.pdf     
  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. 4th ed (with text revision). APA, 2000. & DSM-5 APA 2013 https://doi.org/10.1176/appi.books.9780890423349
  3. Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 2006;368:210-5. https://doi.org/10.1016/s0140-6736(06)69041-7
  4. Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR 2009;58(SS10):1-20. www.cdc.gov/mmwr/preview/mmwrhtml/ss5810a1.htm. https://doi.org/10.15585/mmwr.mm6745a7
  5. Brugha T, McManus, S Bankart, J Scott F, Purdon S, Smith, J Bebbington, P Jenkins, R Meltzer H Epidemiology of Autism Spectrum Disorders in Adults in the Community in England Arch Gen Psychiatry. 2011;68(5):459-465. doi:10.1001/archgenpsychiatry.2011.38. https://doi.org/10.1001/archgenpsychiatry.2011.38
  6. National Institute for Health and Care Excellence. Autism: the management and support of children and young people on the autism spectrum. (Clinical guideline 170) 2013. http://guidance.nice.org.uk/CG170 .  
  7. National Institute for Health and Care Excellence. Autism diagnosis in children and young people: recognition, referral and diagnosis of children and young people on the autism spectrum. (Clinical guideline 128.) 2011. http://guidance.nice.org.uk/CG128. https://doi.org/10.12968/cypn.2016.10.35
  8. National Institute for Health and Care Excellence. Autism: recognition, referral, diagnosis and management of adults on the autism spectrum. (Clinical guideline 142.) 2012. http://guidance.nice.org.uk/CG142.     
  9. Woolfenden S, Sarkozy V, Ridley G, Coory M, Williams. K. A systematic review of two outcomes in autism spectrum disorder – epilepsy and mortality Developmental Medicine & Child NeurologyVolume 54, Issue 4, pages 306–312, April 2012 https://doi.org/10.1111/j.1469-8749.2012.04223.x